EUVIMEDEUVIMED entdecken
Crossref

26-A-16420-ACC APIXABAN VERSUS RIVAROXABAN IN ATRIAL FIBRILLATION PATIENTS RECEIVING CONCOMITANT DILTIAZEM

Isadora Guarino, Saman Nazarian

JACC · 2026-04 · 87 (13) · A130

DOI: 10.1016/j.jacc.2026.02.327 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JACC, 2026-04. Verfasst von Isadora Guarino und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Guarino, I., & Nazarian, S. (2026). 26-A-16420-ACC APIXABAN VERSUS RIVAROXABAN IN ATRIAL FIBRILLATION PATIENTS RECEIVING CONCOMITANT DILTIAZEM. JACC, 87(13), A130. https://doi.org/10.1016/j.jacc.2026.02.327

Vancouver

Guarino I, Nazarian S. 26-A-16420-ACC APIXABAN VERSUS RIVAROXABAN IN ATRIAL FIBRILLATION PATIENTS RECEIVING CONCOMITANT DILTIAZEM. JACC. 2026;87(13):A130. doi:10.1016/j.jacc.2026.02.327

BibTeX
@article{Guarino2026,
  author = {Guarino, Isadora and Nazarian, Saman},
  title = {26-A-16420-ACC APIXABAN VERSUS RIVAROXABAN IN ATRIAL FIBRILLATION PATIENTS RECEIVING CONCOMITANT DILTIAZEM},
  journal = {JACC},
  year = {2026},
  volume = {87},
  number = {13},
  pages = {A130},
  doi = {10.1016/j.jacc.2026.02.327}
}
Kostenlos starten →